Serum miR-30c Level Predicted Cardiotoxicity in Non-small Cell Lung Cancer Patients Treated with Bevacizumab
Crossref DOI link: https://doi.org/10.1007/s12012-018-9457-z
Published Online: 2018-05-08
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Fang
Lu, Xike
Zhang, Xun
Text and Data Mining valid from 2018-05-08
Article History
First Online: 8 May 2018
Compliance with Ethical Standards
:
: The authors declare no conflict of interest.